AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy
Clinical trial NCT00372944 · COMPLETED
Trial details
- NCT number
- NCT00372944
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2008-04-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.